Harvard Medical School, Boston, MA, USA.
Yale School of Public Health, New Haven, CT, USA.
Med Care Res Rev. 2023 Aug;80(4):410-422. doi: 10.1177/10775587231162681. Epub 2023 Apr 10.
Medications for opioid use disorder (MOUD) remain highly inaccessible despite demonstrated effectiveness. We examine the extent of screening for opioid use and availability of MOUD in a national cross-section of multi-physician primary care and multispecialty practices. Drawing on an existing framework to characterize the internal and environmental context, we assess socio-technical, organizational-managerial, market-based, and state-regulation factors associated with the use of opioid screening and offering of MOUD in a practice. A total of 26.2% of practices offered MOUD, while 69.4% of practices screened for opioid use. Having advanced health information technology functionality was positively associated with both screening for opioid use and offering MOUD in a practice, while access to on-site behavioral clinicians was positively associated with offering MOUD in adjusted models. These results suggest that improving access to information and expertise may enable physician practices to respond more effectively to the nation's ongoing opioid epidemic.
尽管已经证明药物治疗阿片类药物使用障碍(MOUD)非常有效,但药物仍然难以获得。我们调查了全国多医师初级保健和多专科实践中阿片类药物使用筛查和 MOUD 可及性的程度。我们利用现有的框架来描述内部和环境背景,评估与实践中使用阿片类药物筛查和提供 MOUD 相关的社会技术、组织管理、基于市场和国家监管因素。共有 26.2%的实践提供 MOUD,而 69.4%的实践对阿片类药物使用进行了筛查。在调整后的模型中,拥有先进的健康信息技术功能与对阿片类药物使用的筛查以及在实践中提供 MOUD 均呈正相关,而获得现场行为临床医生则与提供 MOUD 呈正相关。这些结果表明,改善信息和专业知识的获取可能使医生实践能够更有效地应对全国范围内持续的阿片类药物流行。